{"id":"clm_ADA1FFC461F7","entity":"amgen","predicate":"cash_and_equivalents","value":"34,248,000,000 United States dollar","value_json":{"fp":"Q2","fy":2023,"accn":"0000318154-23-000053","form":"10-Q","filed":"2023-08-04","period":"Q2 FY2023","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2023-06-30","valid_to":"2023-09-30","published":"2023-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Amgen cash and equivalents: 34,248,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_ADA1FFC461F7, https://asof.is/claim/clm_ADA1FFC461F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000053/0000318154-23-000053-index.htm.","url":"https://asof.is/claim/clm_ADA1FFC461F7","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49C1DCF00977","supersedes":["clm_0B4F8228696C"],"first_seen_at":"2026-11-08T15:38:26.099962+00:00","updated_at":"2026-11-08T15:38:34.205395+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/318154/000031815423000053/0000318154-23-000053-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2023","published_at":"2023-08-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-04"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}